drugset / Press release
Emergent BioSolutions to Expand Front Line CLL Clinical Trial of TRU-016 and Rituximab Based on Strong Patient Enrollment and Encouraging Early Clinical Data
2013-04-05 · Emergent BioSolutions · original emergentbiosolutions.com ↗
040513 - TRU-016 and Rituximab FL CLL Expansion (16009) FINAL.pdf 201 KB
The release as fetched from its publisher. emergentbiosolutions.com ↗